 |
Welcome, Introduction, and Program Overview
Sharon Longton, BSN, RN, CNN, CCTC
|
|
Management of Anemia in the Dialysis Population - 1
George Aronoff, MD, MS, FACP |
|
Management of Anemia in the Dialysis Population - 2
Mary Schira, PhD, RN, ACNP, BC, CNN-NP |
|
Panel Discussion
George Aronoff and
Mary Schira |
At the completion of this activity, the participant should be able to:
 |
Summarize the pathophysiologic reasons for anemia in individuals with chronic kidney disease (CKD), particularly in the later stages |
|
Outline a plan of care to address iron deficiency anemia in the dialysis population, including pharmaceutical treatment |
|
Summarize the nursing assessment and patient education that are necessary when treating dialysis patients for anemia |
|
Integrate outcomes for treatment of anemia in the dialysis population into practice |
|
George Aronoff, MD, MS, FACP
Chief of Nephrology and Hypertension
Professor of Medicine and Pharmacology
University of Louisville School of Medicine
Louisville, KY
Mary Schira, PhD, RN, ACNP, BC, CNN-NP
Associate Dean and Associate Professor, MSN Program,
The University of Texas at Arlington School of Nursing,
Arlington, TX
|
|
 |
This activity
has been planned and produced in accordance with
CE guidelines and policies. From a CE symposium
held in April 2009 at the American Nephrology
Nurses' Association (ANNA) National Symposium in San Diego, California.
This activity provides 1.25 contact hours.
The American Nephrology Nurses’ Association (ANNA) is accredited as a provider
of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.
ANNA is a Provider approved by the California Board of Registered Nursing, provider number CEP 00910 for 1.25 contact hours.
|
 |
Posting Date: October 15, 2009
CE Credit Eligible
Through: October 15, 2011
CE Credit Hours/Completion Time: 1.25
Target Audiences: Nephrology nurses and technicians.
Method of participation: Listen to the talk, read the PubMed
abstracts linked to data slides and talk references, take the post-test, read
the linked abstracts in the post-test answer feedback material. |
 |
| SPEAKER DISCLOSURE STATEMENT: |
See individual talks.
This ANNA National symposium was developed by ANNA and sponsored by an educational grant from Fresenius Medical Care of North America.
| ANNA and HDCN CE POLICY
STATEMENTS: |
The CE policy and disclosure statements of the American Nephrology Nurses' Association
are given in detail on the Symposium
Home Page. The CE policy statements of HDCN are
listed on this page. |
|
